Tumor hypoxia, a result of rapid cell proliferation combined with disordered vascular development [9], [10] and subsequent expression of CA IX, is also correlated to metastasis, poor prognosis and resistance to therapeutic intervention making CA IX an important biomarker in the study of hypoxia, tumor cell proliferation and therapy [11]–[19]. This evidence concerns the gene CA9 and neoplasm.